Envoy Medical CEO to Present at Virtual Investor Frum on June 12th.
ByAinvest
Wednesday, Jun 11, 2025 8:36 am ET1min read
COCH--
The virtual forum will feature a live presentation by CEO Lucas, followed by a Q&A session where investors can ask questions in real-time. For those unable to attend the live event, a recorded webcast will be made available after the event. The event will also offer one-on-one meeting opportunities with Envoy Medical representatives from June 12th through June 17th [1].
Envoy Medical is known for its fully implanted hearing devices, including the Esteem® active middle ear implant and the fully implanted Acclaim® cochlear implant. The Esteem device, approved by the FDA, offers 24/7 hearing capability using the ear's natural anatomy, while the Acclaim cochlear implant is an investigational device that leverages the ear's natural anatomy to capture sound [1].
The company has recently achieved significant milestones in its clinical trials for the Acclaim cochlear implant, which is expected to address severe to profound sensorineural hearing loss not adequately addressed by hearing aids [1]. The Acclaim CI received the Breakthrough Device Designation from the FDA in 2019, highlighting its potential to revolutionize hearing technology [1].
Investors interested in attending the event are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The event will be held at www.virtualinvestorconferences.com [1].
References:
[1] https://www.globenewswire.com/news-release/2025/06/11/3097537/0/en/Envoy-Medical-to-Present-at-the-Life-Sciences-Virtual-Investor-Forum-June-12th.html
Envoy Medical, a hearing health company, announced CEO Brent Lucas will present at the Life Sciences Virtual Investor Frum on June 12th. The event will be live and interactive, allowing investors to ask questions in real-time. A recorded webcast will also be available for those unable to attend.
Envoy Medical, Inc. (NASDAQ: COCH), a pioneering hearing health company, has announced that its CEO, Brent Lucas, will present at the upcoming Life Sciences Virtual Investor Forum on June 12th, 2025. The event, hosted by VirtualInvestorConferences.com, will provide an interactive platform for investors to engage with the company and learn more about its innovative hearing technologies [1].The virtual forum will feature a live presentation by CEO Lucas, followed by a Q&A session where investors can ask questions in real-time. For those unable to attend the live event, a recorded webcast will be made available after the event. The event will also offer one-on-one meeting opportunities with Envoy Medical representatives from June 12th through June 17th [1].
Envoy Medical is known for its fully implanted hearing devices, including the Esteem® active middle ear implant and the fully implanted Acclaim® cochlear implant. The Esteem device, approved by the FDA, offers 24/7 hearing capability using the ear's natural anatomy, while the Acclaim cochlear implant is an investigational device that leverages the ear's natural anatomy to capture sound [1].
The company has recently achieved significant milestones in its clinical trials for the Acclaim cochlear implant, which is expected to address severe to profound sensorineural hearing loss not adequately addressed by hearing aids [1]. The Acclaim CI received the Breakthrough Device Designation from the FDA in 2019, highlighting its potential to revolutionize hearing technology [1].
Investors interested in attending the event are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The event will be held at www.virtualinvestorconferences.com [1].
References:
[1] https://www.globenewswire.com/news-release/2025/06/11/3097537/0/en/Envoy-Medical-to-Present-at-the-Life-Sciences-Virtual-Investor-Forum-June-12th.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet